Which of the following is NOT a CNS-active drug class listed in the Beers polypharmacy context?

Study for the AGS Beers Criteria Test. Prepare with flashcards and multiple choice questions, each with hints and explanations. Get ready for your exam with comprehensive resources!

Multiple Choice

Which of the following is NOT a CNS-active drug class listed in the Beers polypharmacy context?

Explanation:
In the Beers Criteria, the concern about polypharmacy often centers on drugs that directly affect the central nervous system in older adults, because these meds raise risks like sedation, confusion, delirium, and falls when used with other CNS-active drugs. Antiepileptics and antidepressants are classic CNS-active classes tied to these risks, and benzodiazepines are well known for causing sedation and cognitive impairment in the elderly. Beta-blockers, on the other hand, are primarily cardiovascular agents. While some can cause fatigue or dizziness, they’re not categorized as a CNS-active drug class within the Beers polypharmacy framework. That’s why they’re the choice that isn’t listed as a CNS-active class in this context.

In the Beers Criteria, the concern about polypharmacy often centers on drugs that directly affect the central nervous system in older adults, because these meds raise risks like sedation, confusion, delirium, and falls when used with other CNS-active drugs. Antiepileptics and antidepressants are classic CNS-active classes tied to these risks, and benzodiazepines are well known for causing sedation and cognitive impairment in the elderly.

Beta-blockers, on the other hand, are primarily cardiovascular agents. While some can cause fatigue or dizziness, they’re not categorized as a CNS-active drug class within the Beers polypharmacy framework. That’s why they’re the choice that isn’t listed as a CNS-active class in this context.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy